Literature DB >> 15459677

Glycomics: a pathway to a class of new and improved therapeutics.

Zachary Shriver1, S Raguram, Ram Sasisekharan.   

Abstract

Complex glycans that are located at the surface of cells, deposited in the extracellular matrix and attached to soluble signalling molecules have a crucial role in the phenotypic expression of cellular genotypes. However, owing to their structural complexity and some redundancy in terms of structures that elicit a function, the therapeutic potential of complex glycans has not been well exploited, with a few notable exceptions. This review outlines recent advances that promise to increase our ability to use complex glycans as therapeutics. Opportunities for the development of further structure-function relationships for these complex molecules are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459677     DOI: 10.1038/nrd1521

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  51 in total

Review 1.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

2.  Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach.

Authors:  Yongmei Xu; Zhen Wang; Renpeng Liu; Arlene S Bridges; Xuefei Huang; Jian Liu
Journal:  Glycobiology       Date:  2011-08-11       Impact factor: 4.313

3.  Chemoenzymatic design of heparan sulfate oligosaccharides.

Authors:  Renpeng Liu; Yongmei Xu; Miao Chen; Michel Weïwer; Xianxuan Zhou; Arlene S Bridges; Paul L DeAngelis; Qisheng Zhang; Robert J Linhardt; Jian Liu
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

4.  A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.

Authors:  Philipp N Spahn; Anders H Hansen; Henning G Hansen; Johnny Arnsdorf; Helene F Kildegaard; Nathan E Lewis
Journal:  Metab Eng       Date:  2015-10-29       Impact factor: 9.783

5.  Quantifiable fluorescent glycan microarrays.

Authors:  Xuezheng Song; Baoyun Xia; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Glycoconj J       Date:  2007-09-01       Impact factor: 2.916

6.  Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Jeong Uk Choi; Farzana Alam; Jooho Park; Seong Who Kim; Sang Yoon Kim; Fakhrul Ahsan; In-San Kim; Youngro Byun
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

7.  Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.

Authors:  Ronald Copeland; Arun Balasubramaniam; Vaibhav Tiwari; Fuming Zhang; Arlene Bridges; Robert J Linhardt; Deepak Shukla; Jian Liu
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

Review 8.  Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma.

Authors:  Hussein Abou-Abbass; Hadi Abou-El-Hassan; Hisham Bahmad; Kazem Zibara; Abir Zebian; Rabab Youssef; Joy Ismail; Rui Zhu; Shiyue Zhou; Xue Dong; Mayse Nasser; Marwan Bahmad; Hala Darwish; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-04-04       Impact factor: 3.535

Review 9.  Understanding the substrate specificity of the heparan sulfate sulfotransferases by an integrated biosynthetic and crystallographic approach.

Authors:  Jian Liu; Andrea F Moon; Juzheng Sheng; Lars C Pedersen
Journal:  Curr Opin Struct Biol       Date:  2012-07-26       Impact factor: 6.809

10.  Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase.

Authors:  Chunhui Liu; Juzheng Sheng; Juno M Krahn; Lalith Perera; Yongmei Xu; Po-Hung Hsieh; Wenfang Dou; Jian Liu; Lars C Pedersen
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.